Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Selling stock requires both a Seller and a Buyer
<<<<<<<<< You have an immediate double of your money >>>>>>>>>
As I have said several times, there is no market for billions of BIEL shares unless BIEL becomes profitable. That 50% conversion discount is worthless if no one wants to buy the shares. It is "laughable" to think that some do not comprehend this.
BIEL lenders take a risk just as BIEL shareholders do. The fact that BIEL insiders, who have a much clearer picture of BIEL, keep loaning more cash to BIEL is an indicator for me.
If your "NO CHOICE" theory was correct why would those same lenders loan another $296k in 2022? (per Q3 data)
It sounds more like my theory, "They did this because they want BIEL to succeed.", is correct.
Issue date ....Amount ... Maturity .... Noteholder
1/3/2022 ....... $ 50,000 ... 1/3/2024 ....... Richard Staelin
2/4/2022 ....... $ 16,000 ....2/4/2024 ....... St. John's LLC
2/9/2022 ....... $ 40,000 ....2/9/2024 ....... St. John's LLC
6/27/2022 ..... $ 10,000 ....6/27/2024 ..... St. John's LLC
6/24/2022 ..... $ 30,000 ....6/24/2024 ..... Richard Staelin
7/6/2022 ....... $ 25,000 ... 12/31/2022 .... Erin Sanders
7/15/2022 .... $ 100,000 .. 7/15/2024 ...... Richard Staelin
9/15/2022 .... $ 15,000 .... 6/27/2024 ...... St. John's LLC
9/30/2022 .... $ 10,000 .....6/27/2024 ...... St. John's LLC
Total 2022 .... $296,000
Good Grief, the lenders could have demanded payment and BIEL would have had to come up with the cash or the shares
<<<<<<<<< What do you consider all those notes that matured in 2022? >>>>>>>>>
BIEL did not hold a gun to their head and force a loan extension. They all worked with BIEL, as most had done on several previous occasions, rolling the loans over for 2 more years. They did this because they want BIEL to succeed.
Ruh-Roh, KT Wave Climbs 16 places on Amazon Best Sellers
<<<<<<< KT~Recovery+Wave, #102 on Amazon muscle stimulators >>>>>>>
"#86 in Muscle Stimulators & Accessories"
If the CanCapital loan was in default I am sure they would have filed legal action against BIEL by now
Let me know when you find the documentation of that lawsuit.
Until that time, "There are no delinquent operating loans".
There are no "delinquent operating loans"
In the case of the convertible loans the lenders have either chosen to convert and been paid back with shares or have chosen to roll over the loans for another 2 years.
Regarding the EXIM loan and other financial institution loans, they are all up to date.
Where is our intrepid 'Trades Reporter' today? I will fill in:
Buys = 11.4 million shares
Sells = 3.9 million shares
Neutral = 1.1 million shares
$74,000 is your latest guess, up from the ridiculous "about $5,000" initial declaration
I still believe the truth is much higher based on the number of Cartons and Transactions.
So $74,000 is Miles Away from the Claim of $5,000 , 14x Away
<<<<<<<<< the following assertion >>>>>>>>>
That "assertion", "Synergy is affiliated with major drug companies", is correct but it did leave out one of Synergy's largest Partners per the 52WMB Bill of Lading information.
$5 billion Sun Pharmaceuticals with 932 Transactions with Synergy..
Important to remember that any valuation on a BOL is going to be at a wholesale level from mfg to distributor not the revenue Synergy earns when they sell the product..
Things seem a bit Fishy on your Synergy Trade Data
I also did a free account set up with 52WMB.
Your post says that "the 15 orders add up to about $5000 USD". As shown below the one shipment with details, the 11/26/2022 shipment, is 4,900 cartons.
The product in this shipment is Jardiance 90/25mg, a Type 2 diabetes drug that will cost you $778 a month with no insurance. How can 4,900 cartons of an expensive Type 2 diabetes drug be valued at "about $5,000 USD" ???
And this is just one of the15 shipments mentioned. The free membership does not give details on the other shipments other than the number of cartons. The other shipments total over 43,000 cartons.
Trade date
2022/11/26
B/L No. (not shown)
——
Supplier - boehringer ingelheim c.a.
Buyers - synergy overseas pvt ltd.
Export Port - sahar air cargo acc inbom4
Import Port - kathmandu tribhuva
Supply area - venezuela
Purchasing area - nepal
Cartons - 4,900
Product description - Jardiance 90/25mg
Thanks for documenting your transaction, the order was placed for 911 shares at .0006
The MM that filled it painted it down to .00055 .
It doesn't matter what the number of shares are in the order. On the OTC retail Traders are limited to 4 digits to the right of the decimal point, as in .0006 .
So when you see 5 or more digits to the right of the decimal point, as in .00055, a MM, for whatever reason, has stepped in and modified that transaction.
Total Nonsense, the Lawyers are the Only Ones that get Anything from a class action lawsuit in Pennyland.
I will take Dr Staelins reputation over anyone on this board
Richard Staelin is the Gregory Mario and Jeremy Mario Professor Emeritusof Business Administration at the Fuqua School of Business, Duke University. He joined Duke in 1982 after teaching at Carnegie-Mellon University for 13 years. He has also been on the faculties of the Australian Graduate School of Management and the University of Chicago. He was Editor of Marketing Science and President of ISMS. He has won best paper awards at Marketing Science, JMR and JM and was awarded the Converse Award and the AMA Best Educators Award. He is an inaugural fellow in ISMS and the AMA and a fellow in INFORMS. He was awarded the best teaching award for the DKU program in 2016.
Current Appointments & Affiliations
Gregory Mario and Jeremy Mario Distinguished Professor, Fuqua School of Business, Duke University 2017
Professor Emeritus of Business Administration, Fuqua School of Business, Duke University 2023
Forgot to mention over 4x more Buys than Sells Today
Buys = 4.059 million shares
Sells = 892k shares
Good Grief, the misinformation abounds
There is zero chance that Dr Staelin, BIEL's COB, and St John's, Patricia Whelan, demand repayment of their loans next month. Ken McLeod, a long time BIEL consultant, will probably to the same. If he should demand to be paid back BIEL would need a new loan or an AS increase if the current remaining AS, 295 million shares, would not cover the conversion.
2022 saw One Loan Conversion. That One Conversion was by St John's so that they would have the cash to make new Non-Convertible Loans to BIEL. They made 5 new Non-Convertible Loans to BIEL in 2022. The first one was one week after the Conversion.
<<<<< In 2022 there was a massive amount of those notes that rolled over >>>>>
"Kicking them down the road" does not make the Loans go away but it does prevent near term dilution which benefits all shareholders. Per the loan agreements BIEL has the option to repay the Convertible Loans in Cash or Shares. So if BIEL is generating profits 2 years down the road or is in a better position to secure conventional loans, cash repayment of the Convertible Loans will be an option
Q3 2022 Financials, page 16
"All accrued interest and principal on the various notes payable are due on or before the end of the month two years from the date of issuance, whether by the payment of cash or by conversion into shares of the Company’s common stock, unless otherwise extended with new terms."
Forgot to Mention that all of those Lenders have Rolled Over Loans in the past
LOL, Steamy Load of Horse Hockey, must not have even watched the video
<<<<<<< you must OWN the stock or borrow stock from a broker >>>>>>>>
LOL, just because the SEC has regulations to prevent Naked Shorting doesn't mean everyone follows those rules. It is against the law to commit bank robbery & murder but tens of thousands of people do it every year.
Dealer Brokers and Market Makers who are more interested in profits than SEC regulations cover up their Naked Shorting in various ways, example;
SEC Brings “Naked Short Selling” Case
May 27, 2021
What Did the BD Allegedly Do Wrong?
"According to the Complaint, the BD mismarked 96% of a certain hedge fund’s short sale orders of two separate issuers’ stock, totaling more than $250 million, as “long” or “short-exempt.” This mismarking allegedly generated $1.6 million in brokerage fees to the BD. The effect of the mismarking was that the hedge fund was able to sell the securities short even though it already had a short position in the securities and did not borrow or locate additional shares to sell short."
"The message to the public markets is that naked short selling can indeed be a practice used to drive down the price of an issuer’s stock."
Those who watched the Gimme Greenbacks video saw 4 CEOs discussing the attacks that have occurred on their companies. One had seen a trading volume of 4x the OS in one day.
The typical scenario is that a Hedge Fund wants to short a company to drive the price down but they have already reached the limit on how much they can Short or they don't want the expenses and commitment of capital that legal Shorting requires. They promise a Broker/MM large commissions if they will Naked Short stock "X".
In the case of BD the Broker falsely marks the Naked Shorting transactions as 'Long' or 'Short Exempt'. It's as easy as checking a box on a form.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171251460
****************************************************************************
<<<<<<<<<< UNLESS I AM DUMPING AS IN PREVIOUS WEEKS >>>>>>>>>>>
What the Hell, after 6 years of doing nothing but trash BIEL you are saying that you own BIEL Shares!!
When someone tells you who they Really Are believe them
Thanks GG, contrary to what some on this board want you to think Naked Shorting is alive and well, stealing money from companies and shareholders every day.
Your "Facts" have some Major Fallacies
<<<<<<<< to do who knows what >>>>>>>>>
The FDA was stuck in the 1950's as far as the 'Mechanism of Action' for Shortwave Therapies so unlike many 510Ks that get the 'Me Too' treatment for their 510k Clearance the FDA wanted Clinical proof of efficacy for Pain Relief. BIEL supplied that:
RecoveryRx FDA Cleared on K190251 for Post Operative Pain with 2 Clinical Trials
https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190251.pdf
ActiPatch FDA Cleared on K152432 for Plantar Fasciitis of the Heel/Osteoarthritis of the Knee with 2 Clinical Trials. BIEL had Led the Way in 2015 to secure an FDA Reclassification for ActiPatch from a Class 3 Device, which is for devices like Pacemakers that are life sustaining, to a Class 2 Device which can include OTC Clearance. The FDA created a new Product Code and Name, 'PQY, Nonthermal Shortwave Therapy. This set up the Over the Counter Clearance in in 2017.
https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf
ActiPatch 2020 FDA Cleared on K192234 for Musculoskeletal Pain, this includes every muscle, joint and bone in the body, with 3 Clinical Trials, Cervical Osteoarthritis, Osteoarthritis of the Knee and Plantar Fasciitis.
https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192234.pdf
That does not sound like " to do who knows what".
******************************************************************
<<<<<<<<<< BOOTS booted BIEL >>>>>>>>>
BIEL sold successfully in the UK in 2014-2017. ActiPatch sold in over a thousand Boots stores as well as several other pharmacy chains. This retail marketing saw several of BIEL's largest revenue years. However, the costs associated with paying 'Slotting Fees', paying rent for shelf space, in thousands of stores ended up causing some of BIEL's largest yearly losses.
When BIEL received the NHS Approval in 2018 they pulled the ActiPatch from most retail stores feeling that demand would drop at these stores with patients using their NHS coverage.
*********************************************************
<<<<<<<<<<< that clearance came in 2/2016 >>>>>>>>>>>>
There was no FDA Clearance in 2016. The first ActiPatch OTC Clearance came in 2017 for two medical indications, as documented above.
The significant OTC FDA Clearance came in 2020, Musculoskeletal Pain. This meant that Actipatch was now FDA Authorized for Pain on every Muscle. Joint, Ligament, and Bone.
**************************************************************
<<<<<< relationship with the EX-IM bank on supposed " Loan Guarantees" >>>>>>>>
This is no mystery. As BIEL's largest Lender IBEX was granted rights to all BIEL Property as security for the loans. In 2018 when BIEL wanted to extend the EXIM Loans they wanted and received the right to being first in line for BIEL assets, ahead of IBEX.
Q3 2022 Financials page 16
"According to the original Security Agreement dated August 1, 2009, the Company grants IBEX a security interest in, all of the right, title, and interest of the Company, in and to all of the Company’s personal property and intellectual property, and all proceeds or replacements as collateral for the convertible promissory note agreements. The Security Agreement has been subordinated to the EX-IM Bank."
https://www.otcmarkets.com/otcapi/company/financial-report/351692/content
Please Show Me Where BIEL Used Cash to Pay Back a Convertible Loan
<<<<< rollovers are not because the family is suddenly stockholder friendly, it's because there is no money to payback their loans >>>>>
It Has Not Happened. Shares in BIEL are used to pay back the Convertible Loans.
Rolling Over the Convertible Loans helps Stockholders by not diluting their BIEL Shares.
<<<<<< same reason for foregoing the interest >>>>>>
The Interest on Convertible Loans has never been paid back in Cash. It has been added to the Loan and paid back upon Conversion. Geeezzzz!
BIEL could have raised the AS and continued to pay back the Convertible Loans in Stock, diluting existing shareholders, they did not. That sounds "Shareholder Friendly" to me.
As far as Kicking the Loans Down the Road for another 2 years. It takes 20 times more shares to pay off a Convertible Loan at a .0005 SP than at a .01 SP.
The only way IBEX, St John's, Staelin get their Loans repaid is when BIEL is Profitable
<<<<<<<< The note holders must get paid eventually >>>>>>>>>>
IBEX was the only lender who had priority to recover assets in the event of BIEL's BK. IBEX lost this priority to the EXIM Bank several years ago.
The combined debt to the top 3 lenders is over $11 million. BIEL's assets in a BK scenario will not cover this debt. IMO, that is how we know KW, PW, Dr Staelin are doing everything possible to make BIEL a success, it could very well determine if they get their investments repaid.
We saw the commitment to BIEL's success in the millions of dollars in Loan Roll Overs that have occurred. IBEX, St John's and Dr Staelin all have Loans dating back to 2017 that have been Rolled Over numerous times.
We saw the commitment to BIEL's success in the $2.5 million in Interest foregoing over the last 3 years by IBEX and St John's.
We saw the commitment to BIEL's success in the Nonconvertible Loans that St John's and Dr Staelin have made to BIEL over the last two years.
Yep GG, in addition to the timing of the 911 trade the MMs backed way off on the Shorting yesterday with only 1.2 million shares Shorted out of a 6.1 million share total volume.
Nice to see that 3 million share Buy at 3:42 and the Buy/Sell ratio 50k shares away from parity.
date .. symbol .. short vol... total vol
20230217|BIEL|1290911|0|6152303
20230216|BIEL|5659010|0|8129869
20230215|BIEL|2095000|0|2808000
20230214|BIEL|14637723|0|19475631
20230213|BIEL|162000|0|371000
So you would rather have BIEL cease operations rather than work with lenders, Rolling Over loans for another 2 years, giving BIEL and its Partners time to find the correct marketing to educate consumers on PSWT and sell products.
Got it, nice to know where you stand.
As far as Sales not covering operational costs, look at the Net Losses and Dilution 5-10 years ago compared to the period since KW took over and tell me BIEL has not made significant progress towards solvency.
What a Load of BS
<<<<<<<<<<<<< SALES BOTTOM OF THE BARREL >>>>>>>>>>>>>>>
This page displays the 5 products DonJoy lists under its Recovery-Pain Management classification. The 2 'Fast Freeze ' products have been discounted by 68% which is why they currently have more sales.
All three of the 'Powered by ActiPatch' products are priced at the full RRP.
https://www.donjoyperformance.com/pain-management
Didn't your DD show that there was only one Convertible Loan conversion in 2022?
St John's converted a Loan on 1/25/2022 and that was the only one per the Q3 financials.
What did St John's do a week after that conversion? They started making new Loans to BIEL, 5 that we know of, on an Interest Only basis, no conversion to shares option.
Multiple BIEL lenders want BIEL to succeed and are following the lead of IBEX, St John's and Dr Staelin in Rolling Over their Loans for another 2 years.
News Flash, KT Wave is not a 'Muscle Stimulator'
<<<<<<<< #100 on Amazon muscle stimulators >>>>>>>>
The Wave is a PSWT FDA Cleared Medical Device for the Relief of Musculoskeletal Pain.
Said the same thing in October & BIEL is still around 4 months later
<<<<<<<<< the coup de grâce is nigh >>>>>>>>>
Monday, October 10, 2022 3:42:56 PM
"Coming to an end. Finally THIS SCAM IS OVER."
*********************************************************
And May,
Thursday, May 19, 2022 11:24:49 AM
"Biel is DEAD over done with"
*********************************************************
And April,
Wednesday, April 27, 2022 12:09:42 PM
"I am expecting a BK filing frankly."
Same cries of, Wolf, heard over and over again but the Wolf never appears
The truth is BIEL is overdue for news. Yesterday few wanted to Sell at 5 and few wanted to Buy at 6.
Pretty simple.
I would agree with that sentiment Hawk
<<<<<<<<< BIEL should give an update >>>>>>>>>
Only adding that it should have occurred at the end of 2022 or the first week of 2023.
In this context "Interest Only" means Loans are 'Not Convertible', No Conversion into BIEL Shares = No Dilution
<<<<<< forgo interest on their convertible notes for 2020, and continuing into 2022 >>>>>>
Everyone was complaining about the 'Convertible loans' and their 50% discount to the share price.
Dr Staelin & St John's said, OK, and have made No new 'Convertible Loans' since December 10th of 2019. Both parties have continued to Roll Over their old convertible loans for another 2 years as they come due.
For the years 2020, 2021 & 2022 IBEX and St John's have forgone Interest on their Convertible Loans. This has saved BIEL $2.5 million.
Kelly Whelan's last new loan was initiated on 10/17/2019. Her last loan conversion to shares was on 3/22/2019. Since March of 2019 she has extended all her loans for two more years as they came due.
More Scare Tactics, All These Lenders Have Rolled Over Loans Previously
Ken McLeod, BIEL Consultant
Dr Staelin, BIEL Chairman of the Board, $550k in Interest Only Loans since return to COB
St John's, controlled by Patricia Whelan, $81k in Interest Only Loans in 2022
That was a MM Parlor Trick
<<<<<<<<< look at today's price results 0.00045 >>>>>>>>>>
A Market Maker executed this $27 trade at 9:30:00 to try and create a negative sentiment among traders . Anytime a Trading price with five digits to the right of the decimal point shows up it comes from a MM/Broker-Dealer because retail traders can not place an order with 5 or more digits right of the decimal point.
The 5 Bid Size is now 13 million shares.
Yes pinhigh, Volume on news is one solution that seems to get the MMs to back off.
Around 300 million shares usually does it. Beyond that and to maintain gains a steady flow of increasing earnings creates a harder job for MMs to manipulate. Down the road moves up the OTC Markets food chain to OTCQB, .01 minimum Bid, and then OTCQX, .10 minimum Bid, stabilizes BIEL further.
The SEC implemented Regulation SHO in 2005 because Market Makers and Brokers were abusing Naked Shorting. Under Regulation SHO MMs can still Naked Short if under their own opinion that they are doing so to 'Make a Market'. They have 3 days to cover their Shorting and deliver the shares to the Buyer. If the MM doesn't cover their Short in 3 days there are no serious consequences until day 13.
In many volatile Penny Stocks 3 days is plenty of time 'Kill a Run' or create a 'False Dive' in a SP and cover the shorting.
The proof that Naked Short Selling is still a problem are the cases that the SEC/FINRA bring against Brokers/MMs. For every 1 that they catch there are dozens that get away with it. Most will remember the high profile Naked Shorting cases like Game Stop and Overstock. The infamous Bernie Madoff, a former chairman of the NASDAQ stock exchange, was a Broker-Dealer who was heavily into Naked Shorting before his scheme fell apart.
The organizations behind the stock market, OTC Markets, FINRA, ect., tend to down play the damage that Naked Shorting can do as they want to portray their Markets as safe for investors. Many times the illegal use of shorting continues until an insider blows the whistle.
SEC Charges Chicago-Based Broker-Dealer with Violations of Regulation SHO
ADMINISTRATIVE PROCEEDING
File No. 3-20961
August 12, 2022 - The Securities and Exchange Commission today announced settled charges against Chicago-based registered broker-dealer IMC Chicago, LLC ("IMC") for violations of Rule 203(b)(1) of Regulation SHO through its Single-Dealer Platform ("SDP").
The SEC's order finds that from approximately June 2017 through November 2020, IMC violated Regulation SHO by executing millions of short sale trades through the SDP while improperly relying on the bona-fide market making exception to the "locate requirement" for short sales in Rule 203(b)(2)(iii). The order finds that IMC did not qualify for the bona-fide market making exception to the locate requirement because it was not engaged in bona-fide market making on the SDP at the time of these short sales.
********************************************************************
FINRA Penalizes UBS Securities $2.5M for 73,000 ‘Naked’ Short Sales (doing it for 9 years before they got caught)
Wednesday, 05/10/2022 | 10:58 GMT by Solomon Oladipupo
The self-regulatory organization, which supervises brokerage firms in the United States, said UBS Securities violated Rule 204 of the US Securities and Exchange Commission’s Regulation SHO (Reg SHO).
Additionally, the brokerage’s supervisory failures to uphold Reg SHO rules within a period of nine years attracted the penalty, FINRA announced on Wednesday.
Reg SHO, a set of rules introduced in 2005, regulates the practice of short sales or the sale of borrowed securities in the United States.
According to FINRA, the rule “requires firms to take affirmative action to close out ‘failure to deliver’ positions resulting from short sales in equity securities by borrowing or purchasing the securities by the beginning of regular trading hours the day after the settlement date.”
However, the private regulator said it found at least 5,300 ‘failure to deliver’ positions in UBS' systems between 2009 and 2018.
************************************************************
FINRA Penalties And Regulation SHO Breaches At WEDBUSH Securities[/
|
2022-09-29 01:20
Wedbush Securities, Inc. violated Regulation SHO Rules 204(a), (b), and (c) and FINRA Rule 2010 by failing to timely close out 2,056 fail-to-deliver positions as required by Rule 204(a), failing to place securities in the "penalty box" as required by Rule 204(b), and failing to comply with the notice requirement of Rule 204(c).
***************************************************************
The Regulation SHO Daily Report is one of the few tools investors have to discern what MMs did on a given day.
That Opinion has been Wrong the last 50 times it was posted
<<<<<<<<<<<<<< Chapter 7 is imminent >>>>>>>>>>>>>>
Why would anyone give the 51st declaration any more significance than the previous 50 failed Opinions???
Yep Tantalos, that was the MMs playing their games, selling shares they don't own at .00045.
64 million shares in Naked Shorting on Friday. That is 86% of yesterday's Volume. Any stock can be held down if 86% of their day's Volume is Naked Shorting.
Date ..... Symbol .. Short Vol .... Total Vol
20230210 | BIEL | 64472430 || 74670475
Forgot to mention 13 million more Buys than Sells today
Buys = 40 million shares
Sells = 27 million shares
Neutral = 6 million shares
MM Shorting = 64 million shares
20230210|BIEL|64472430|0|74670475
Important to remember JIS is part of the Ortho Alliance, thanks Hawk
"OUR GROWTH GOALS
We see tremendous growth opportunities by recruiting best-in-class providers, opening new clinical and surgical facilities, expanding patient care and support services, and partnering with market-leading orthopedic groups.
Our strategic and healthcare expertise allows your pratice to expand while maintaining the highest levels of quality patient care.
We currently have more than 70 providers working in 25+ offices across Ohio, Kentucky and Indiana."
https://joinorthoalliance.com/
Dr. Keith Berend is the Chief Medical Development Officer for all of the Ortho Alliance providers.
When he tries something at JIS and likes it he would most likely recommend it to all of the Ortho Alliance providers.
Whenever there are large amounts of money at stake there will be Lobbying and Corruption
<<<<<<< Vaccines for covid were approved under emergency authorizations and were (almost certainly) not influenced by lobbying. >>>>>>>
Inside the powerful political machines that COVID-19 vaccine makers Pfizer, Moderna, and AstraZeneca have built in DC Business Insider Dec 8, 2020
Pfizer, AstraZeneca and Moderna have been developing more than just a vaccine to stop the spread of the coronavirus.
The pharmaceutical companies have also been building notable political influence in Washington as they seek to sway federal policy and spending in their favor.
The companies have together hired an army of lobbyists and contributed millions of dollars to political causes during 2019 and 2020, according to an Insider analysis of federal lobbying, campaign finance, and other records.
Pfizer for instance is on pace to spend more than $11.3 million on federal-level lobbying efforts in 2020, which would rank among its highest annual totals during the past decade.
Emergency authorization of the Pfizer and Moderna vaccines could come within days.
https://www.businessinsider.com/pfizer-moderna-astrazeneca-vaccine-coronavirus-covid19-lobbyists-washington-2020-12?op=1
How The Covid-19 Vaccine Injected Billions Into Big Pharma—And Made Its Executives Very Rich
Forbes May 14, 2021
https://www.forbes.com/sites/forbesdigitalcovers/2021/05/14/virus-book-excerpt-nina-burleigh-how-the-covid-19-vaccine-injected-billions-into-big-pharma-albert-bourla-moncef-slaoui/?sh=417734117d80
Frederick Office of Economic Development promotes BIEL
FITCI Graduate Success Stories
4 days ago
"BIOELECTRONICS CORP. is a Frederick County “Top 50 Innovative Businesses” winner for its award-winning consumer medical devices designed to treat both acute and chronic pain. BioElectronics’ medical devices are a pioneering advancement of pulsed shortwave therapy. Their products are U.S. FDA cleared, non-invasive, drug free, and can be used for post-operative pain, musculoskeletal complaints, and wound care while reducing the need for other medications, including opioids."
https://www.discoverfrederickmd.com/business-incubation